Hooks Corwin Dale
Insider CIK 1665347 · CLVS See Remarks · SPRB Chief Commercial Officer · APLT Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SPRB SPRUCE BIOSCIENCES, INC. | A Award deriv | 2026-03-09 | 2026-03-09 | 11,000 | — | $0 | 11,000 | SEC↗ |
| APLT Applied Therapeutics, Inc. | U Tender | 2026-02-03 | 2026-02-03 | 5,753 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics, Inc. | D To issuer | 2026-02-03 | 2026-02-03 | 862,500 | — | $0 | 5,753 | SEC↗ |
| APLT Applied Therapeutics, Inc. | A Award | 2025-12-19 | 2026-02-03 | 312,500 | — | $0 | 868,253 | SEC↗ |
| APLT Applied Therapeutics, Inc. | A Award | 2025-03-24 | 2025-03-26 | 250,000 | — | $0 | 550,000 | SEC↗ |
| APLT Applied Therapeutics, Inc. | A Award | 2024-04-12 | 2024-04-15 | 300,000 | — | $0 | 300,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2018-09-05 | 2018-09-07 | 469 | — | $0 | 4,688 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2018-09-05 | 2018-09-07 | 239 | $35.75 | $8.5K | 5,349 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2018-09-05 | 2018-09-07 | 469 | — | $0 | 5,588 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2018-08-27 | 2018-08-28 | 869 | — | $0 | 6,950 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2018-08-27 | 2018-08-28 | 434 | $35.15 | $15.3K | 5,119 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2018-08-27 | 2018-08-28 | 869 | — | $0 | 5,553 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2018-06-15 | 2018-12-27 | 939 | $45.47 | $42.7K | 1,595 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2018-06-06 | 2018-06-08 | 468 | — | $0 | 5,157 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2018-06-06 | 2018-06-08 | 235 | $47.70 | $11.2K | 4,684 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2018-06-06 | 2018-06-08 | 468 | — | $0 | 4,919 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2018-05-31 | 2018-06-01 | 869 | — | $0 | 7,819 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2018-05-31 | 2018-06-01 | 869 | — | $0 | 3,958 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2018-05-31 | 2018-06-01 | 444 | $48.63 | $21.6K | 4,451 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2018-03-07 | 2018-03-09 | 1,875 | — | $0 | 5,625 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2018-03-07 | 2018-03-09 | 1,875 | — | $0 | 4,964 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2018-03-07 | 2018-03-09 | 938 | $58.43 | $54.8K | 4,026 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2018-03-01 | 2018-03-02 | 869 | — | $0 | 8,688 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2018-03-01 | 2018-03-02 | 9,000 | — | $0 | 9,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2018-03-01 | 2018-03-02 | 9,000 | — | $0 | 9,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2018-03-01 | 2018-03-02 | 869 | — | $0 | 3,556 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2018-03-01 | 2018-03-02 | 467 | $55.51 | $25.9K | 3,089 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2017-11-29 | 2017-12-01 | 868 | — | $0 | 9,557 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2017-11-29 | 2017-12-01 | 331 | $59.49 | $19.7K | 2,687 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2017-11-29 | 2017-12-01 | 868 | — | $0 | 3,018 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2017-08-31 | 2018-12-27 | 2,150 | $76.36 | $164.2K | 19 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2017-08-29 | 2017-09-01 | 1,325 | $72.14 | $95.6K | 2,150 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2017-08-25 | 2017-08-29 | 3,475 | — | $0 | 10,425 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2017-08-25 | 2017-08-29 | 3,475 | — | $0 | 3,475 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2017-08-25 | 2017-08-29 | 1,306 | $73.16 | $95.5K | 2,169 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2017-03-27 | 2017-03-28 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2017-03-27 | 2017-03-28 | 7,500 | — | $0 | 7,500 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2016-08-25 | 2016-08-29 | 27,800 | — | $0 | 27,800 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2016-08-25 | 2016-08-29 | 13,900 | — | $0 | 13,900 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2016-03-01 | 2016-03-02 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2016-02-01 | 2016-02-02 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2016-02-01 | 2016-02-02 | 10,000 | — | $0 | 10,000 | SEC↗ |